Inhibition of SIRT1 deacetylase suppresses estrogen receptor signaling

Carcinogenesis

Volumn 31, Issue 3, 2010, Pages 382-387

  Yao, Yuan ^a   Li, Hongzhe ^b   Gu, Yansong ^b   Davidson, Nancy E ^c   Zhou, Qun ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; SIRTINOL; SIRTUIN 1; BENZAMIDE DERIVATIVE; ESTRADIOL; HYBRID PROTEIN; MESSENGER RNA; NAPHTHOL DERIVATIVE; NICOTINAMIDE; RNA; SIRT1 PROTEIN, HUMAN; SIRT1 PROTEIN, MOUSE; SMALL INTERFERING RNA; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; GENE REPRESSION; HUMAN; HUMAN CELL; MAMMARY GLAND; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETIC TRANSCRIPTION; GENETICS; GERMFREE ANIMAL; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UDDER;

ANIMALS; BENZAMIDES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELLS, CULTURED; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; FIBROBLASTS; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; MICE, KNOCKOUT; NAPHTHOLS; NEOPLASM PROTEINS; NIACINAMIDE; PROMOTER REGIONS, GENETIC; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIRTUIN 1; SPECIFIC PATHOGEN-FREE ORGANISMS; TRANSCRIPTION, GENETIC;

EID: 77950896568     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp308     Document Type: Article

References (36)

1. Yager,J.D. et al. (2006) Estrogen carcinogenesis in breast cancer. N. Engl. J. Med., 354, 270-282.
2. Nilsson,S. et al. (2001) Mechanisms of estrogen action. Physiol. Rev., 81, 1535-1565.
3. McKenna,N.J. et al. (2002) Combinatorial control of gene expression by nuclear receptors and coregulators. Cell, 108, 465-474.
4. Xu,J. et al. (2003) Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol., 17, 1681-1692.
5. Chen,H. et al. (1999) Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell, 98, 675-686.
6. Imai,S. et al. (2000) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature, 403, 795-800.
7. Zhou,Q. et al. (2007) Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation. Cancer Biol. Ther., 6, 64-69.
8. Duong,V. et al. (2004) Histone deacetylase inhibition and estrogen signalling in human breast cancer cells. Biochem. Pharmacol., 68, 1239-1246.
9. Reid,G. et al. (2005) Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A. Oncogene, 24, 4894-4907.
10. Kim,M.Y. et al. (2006) Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. Mol. Endocrinol., 20, 1479-1493.
11. Bixcaku,E. et al. (2008) Selective inhibition of histone deacetylase 2 silences progesterone receptor-mediated signaling. Cancer Res., 68, 1513-1519.
12. Leong,H. et al. (2005) Recruitment of histone deacetylase 4 to the Nterminal region of estrogen receptor alpha. Mol. Endocrinol., 19, 2930-2942.
13. Azuma,K. et al. (2009) Association of estrogen receptor alpha and histone deacetylase 6 causes rapid deacetylation of tubulin in breast cancer cells. Cancer Res., 69, 2935-2940.
14. Saji,S. et al. (2005) Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer. Oncogene, 24, 4531-4539.
15. Bouras,T. et al. (2005) SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J. Biol. Chem., 280, 10264-10276.
16. Balestrieri,M.L. et al. (2008) High glucose downregulates endothelial progenitor cell number via SIRT1. Biochim. Biophys. Acta, 1784, 936-945.
17. Firestein,R. et al. (2008) The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One, 163, e2020.
18. Wang,R.H. et al. (2008) Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell, 14, 312-23.
19. Pagans,S. et al. (2005) SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol., 3, e41.
20. Ota,H. et al. (2006) Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene, 25, 176-85.
21. Jung-Hynes,B. et al. (2009) Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition? J. Biol. Chem., 284, 3823-3832.
22. North,B.J. et al. (2003) The human Sir2 ortholog, SIRT2, is an NAD+dependent tubulin deacetylase. Mol. Cell, 11, 437-444.
23. Li,H. et al. (2007) SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice. Breast Cancer Res., 9, R1.
24. Yao,Y. et al. (2009) A novel antiestrogen agent Shikonin inhibits estrogen dependent gene transcription in human breast cancer cells. Breast Cancer Res. Treat, doi: 10.1007/s10549-009-0547-2.
25. Rodgers,J.T. et al. (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature, 434, 113-118.
26. Denu,J.M. (2005) Vitamin B3 and sirtuin function. Trends Biochem. Sci., 30, 479-483.
27. Grozinger,C.M. et al. (2001) Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J. Biol. Chem., 276, 38837-38843.
28. de Graffenried,L.A. et al. (2002) Sp1 is essential for estrogen receptor alpha gene transcription. J. Steroid Biochem. Mol. Biol., 82, 7-18.
29. Keen,J.C. et al. (2005) Protein phosphatase 2A regulates estrogen receptor alpha (ER) expression through modulation of ER mRNA stability. J. Biol. Chem., 280, 29519-29524.
30. Blander,G. et al. (2004) The Sir2 family of protein deacetylases. Annu. Rev. Biochem., 73, 417-435.
31. Vaquero,A. et al. (2004) Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol. Cell, 16, 93-105.
32. Cheng,H.L. et al. (2003) Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc. Natl Acad. Sci. USA, 100, 10794-10799.
33. Fu,M. et al. (2006) Hormonal control of androgen receptor function through SIRT1. Mol. Cell. Biol., 26, 8122-8135.
34. Dai,Y. et al. (2007) Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor. Mol. Endocrinol., 21, 1807-1821.
35. Kojima,K. et al. (2008) A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Biochem. Biophys. Res. Commun., 373, 423-428.
36. Aoyagi,S. et al. (2008) Nicotinamide uncouples hormone-dependent chromatin remodeling from transcription complex assembly. Mol. Cell. Biol., 28, 30-39.